How long does 25C-NBOH last?

The total duration of 25C-NBOH via sublingual is 5 hours to 7 hours. Onset typically occurs within 15 minutes to 45 minutes.

25C-NBOH — SubstanceWiki

25C-NBOH (2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-hydroxyphenyl)methyl]ethanamine) is a synthetic psychedelic phenethylamine belonging to the NBOH series, structurally related to 2C-C through the addition of an N-(2-hydroxybenzyl) group. Like all NBOH compounds, it acts as a potent agonist at serotonin 5-HT2A receptors and is only active via sublingual or buccal administration, being rapidly metabolized when swallowed.

25C-NBOH is one of the more active NBOH analogs, with reported active doses ranging from 250–750 μg. The experience has been described as broadly similar to 2C-C but with greater visual intensity, a somewhat shorter duration, and a more prominent stimulant component. The compound is considered to carry less acute fatality risk than its NBOMe counterpart (25C-NBOMe), and no confirmed fatalities from 25C-NBOH alone are documented in the scientific literature.

Despite the comparatively lower risk profile relative to NBOMe compounds, 25C-NBOH should not be approached as safe. The dose-response relationship is steep, vasoconstriction is a consistent physiological effect, and the absence of documented fatalities partly reflects that NBOH compounds are significantly less prevalent in drug markets than NBOMe compounds. Accurate dosing is difficult without quantitative testing, and the harm reduction principles applicable to all NBOMe/NBOH compounds apply fully here.

How It Feels

The come-up is gentle by NBOx standards. Twenty to thirty minutes after sublingual administration, a soft warmth begins to bloom in the chest and face. There is the characteristic bitter taste and gum numbness, but the body load is noticeably lighter than its NBOMe cousins. A mild stimulant energy emerges -- a brightening of attention, a subtle quickening of the pulse -- but it lacks the aggressive, wired quality of the more potent compounds in the series. The first visual signs appear as a deepening and enrichment of color, as though the world has been gently dipped in watercolor.

Over the next hour, the visual landscape opens up into something genuinely beautiful. Colors become luminous and richly layered -- greens deepen toward emerald, blues acquire a sapphire glow, and warm tones radiate like embers. Unlike the hard-edged neon geometry of the NBOMe series, the visuals here tend toward softer, more flowing forms. Surfaces breathe and ripple gently. Patterns emerge in organic curves and spirals rather than mechanical grids. There is a painterly quality to the perceptual shifts, as though reality has been rendered in oil rather than digitally processed. Closed-eye visuals present as slowly morphing fields of color -- warm gradients that shift and pool like northern lights viewed through water.

At the peak, reached around ninety minutes to two hours in, the experience settles into a comfortable plateau of moderate psychedelic intensity. The headspace is warm, clear, and gently euphoric. Conversations flow easily, and there is a pleasant sociability to the state -- a softening of social edges without the overwhelming empathogenic push of MDMA. Music is enhanced beautifully, acquiring depth and emotional resonance. The body feels light and relaxed, with only mild residual stimulation. Vasoconstriction is minimal compared to the NBOMe compounds, and nausea is uncommon. The overall character is one of accessible, colorful psychedelia -- visually rewarding without being overwhelming, mentally stimulating without being demanding.

The experience begins to taper around four hours after onset, with visuals gradually fading to a soft shimmer and enhanced color perception. The comedown is smooth and unremarkable, leaving behind a gentle afterglow of warmth and mild visual enhancement that may persist for another hour or two. Total duration runs five to seven hours. The aftermath is clean -- little physical hangover, minimal fatigue, and often a lingering sense of quiet contentment.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(15)

Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
Frequent urination— Increased urinary frequency beyond normal patterns, caused by diuretic effects or bladder irritation...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
Muscle tension— Persistent partial contractions or tightening of muscles that produces uncomfortable stiffness, cram...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...

Cognitive & Perceptual Effects

Visual(20)

After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
Brightness alteration— Perceived increase or decrease in environmental brightness beyond actual illumination levels, common...
Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
Depth perception distortions— Alterations in how the distance of objects within the visual field is perceived, causing layers of s...
Diffraction— The experience of seeing rainbow-like spectrums of color and prismatic halos embedded within bright ...

Detection Methods

Urine Detection

25C-NBOH is not targeted by standard immunoassay-based urine drug screens. However, due to its phenethylamine backbone, there is a theoretical possibility of cross-reactivity with amphetamine immunoassays, though this has not been consistently reported in clinical literature. Specialized LC-MS/MS methods developed for novel psychoactive substances can detect NBOH compounds and their metabolites in urine for approximately 24 to 48 hours after ingestion, depending on dose and individual metabolism.

Blood and Serum Detection

Blood detection windows for 25C-NBOH are relatively short. Peak plasma concentrations occur within 30 minutes to 2 hours depending on the route of administration (sublingual absorption is typical for NBOH compounds). Blood concentrations fall below detectable thresholds within 6 to 16 hours for most methods. LC-MS/MS remains the only reliable analytical approach for serum detection, as the doses involved (typically hundreds of micrograms to low milligrams) produce low absolute concentrations.

Standard Drug Panel Inclusion

25C-NBOH is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. It is not specifically targeted by any routine workplace or clinical immunoassay. While some structural similarity to amphetamines exists, cross-reactivity on amphetamine panels is inconsistent and cannot be relied upon for either detection or exclusion. Identification requires specific testing at a reference laboratory equipped for novel psychoactive substance analysis.

Confirmatory Methods

Definitive identification of 25C-NBOH requires LC-MS/MS or high-resolution mass spectrometry (HRMS). GC-MS can also be employed but may require derivatization due to the thermal lability of NBOH compounds. Reference standards are necessary for quantitative confirmation. Forensic and clinical toxicology laboratories that maintain novel psychoactive substance panels are the only facilities reliably capable of this analysis.

Reagent Testing (Harm Reduction)

Reagent testing is critically important for NBOH compounds due to their significantly higher toxicity profile compared to classical psychedelics. The Ehrlich reagent shows NO reaction with 25C-NBOH, which is the single most important distinguishing test: any substance sold as a psychedelic that fails to turn purple with Ehrlich may be an NBOH compound rather than LSD or a tryptamine. The Marquis reagent produces variable results depending on the specific NBOH compound, ranging from no reaction to green or brown color changes. The Mecke reagent may produce a brown or dark green reaction. For harm reduction purposes, always testing with Ehrlich first is essential. The absence of a purple Ehrlich reaction is a strong warning sign that the substance is not a lysergamide or tryptamine and may be a potentially dangerous NBOH compound.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Acute Toxicity Profile

No confirmed human fatalities specifically attributed to 25C-NBOH alone have been documented in the scientific literature. This is a meaningful distinction from 25C-NBOMe. However, the absence of documented fatalities should not be interpreted as evidence of safety. Confirmed serious adverse events including vasoconstriction, tachycardia, and panic reactions have been reported.

Vasoconstriction

Vasoconstriction is the primary physiological risk of 25C-NBOH, as with all NBOH and NBOMe compounds. Peripheral vasoconstriction manifests as cold, pale, or blue extremities, numbness, and at high doses can compromise peripheral circulation. Risk is substantially elevated by concurrent stimulant use.

Cardiovascular Effects

Elevated heart rate and blood pressure are consistent effects, particularly at higher doses. Those with underlying cardiovascular conditions are at significantly elevated risk.

Psychological Risks

Acute anxiety, paranoia, and panic are common adverse events, particularly at high doses
Challenging thought loops and delusional ideation can occur
The intensity often exceeds user expectations, particularly for those accustomed to classical psychedelics

Drug Interactions

Stimulants — Strongly contraindicated; compound vasoconstriction
Lithium — Absolute contraindication for all psychedelics; seizure risk
MAOIs — Avoid; serotonin syndrome risk
Cannabis — Unpredictably amplifies intensity

Contraindications

Cardiovascular disease, hypertension, or vascular disorders
Personal or family history of schizophrenia or psychosis
Current use of stimulants, lithium, or MAOIs

Addiction Potential

not habit-forming

Overdose Information

LD50potentially fatal at heavy dosages.

25C-NBOH's extreme potency means it should not be insufflated (snorted) as this method of administration has been associated with many deaths and hospitalizations with closely related members of the 25x-NBOMe series.

Germany: 25C-NBOH is controlled under the NpSG (New Psychoactive Substances Act) as of November 26, 2016. Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.
Sweden: The Riksdag added 25C-NBOH to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of August 18, 2015, published by Medical Products Agency (MPA) in regulation HSLF-FS 2015:12
Switzerland: 25C-NBOH is a controlled substance specifically named under Verzeichnis E.
United Kingdom: 25C-NBOH is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.
Responsible use
Research chemical
Psychedelics
Phenethylamines
25x-NBOH
25C-NBOMe
25C-NBOH (Wikipedia)
25C-NBOH (Isomer Design)

Full	almost immediately after ingestion
Half	1 week
Zero	2 weeks

25C-NBOH

Quick Dosage

Dosage

sublingual

Duration

sublingual

How It Feels

Subjective Effects

Physical Effects

Physical(15)

Cognitive & Perceptual Effects

Visual(20)

Pharmacology

Mechanism of Action

Structure-Activity Relationship

Route-Dependency

Pharmacokinetics

Tolerance

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Development

Forensic History

Legal Status

Harm Reduction

Test Your Substance

Sublingual Administration Only

Dose Conservatively

Monitor for Vasoconstriction

Dangerous Combinations to Avoid

Emergency Response

Toxicity & Safety

Acute Toxicity Profile

Vasoconstriction

Cardiovascular Effects

Psychological Risks

Drug Interactions

Contraindications

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (3)

See Also

Similar by Effects

Same Class

References (4)

Frequently Asked Questions

Cognitive(16)

Auditory(3)

Multi-sensory(2)

Transpersonal(3)